Milica Budimir Filimonovic

Dr. Milica Budimir Filimonovic

Vinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Beograd, Serbia
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Biomaterials
Verified
Journal Article
Closed access
Biljana RisticBiljana Ristic
Biljana Ristic
MMMarina M. Milenkovic
Marina M. Milenkovic
IDIvana R. Dakic
Ivana R. Dakic
BMBiljana M. Todorović Marković
Biljana M. Todorović Marković
MMMomir S. Milosavljevic
Momir S. Milosavljevic
VTVladimir Trajkovic
Vladimir Trajkovic

1 August 2014 in Materials Letters
Verified
Journal Article
Closed access
UBUna Bogdanović
Una Bogdanović
Vesna LazicVesna Lazic
Vesna Lazic
VVVesna (Vuković) Vodnik
Vesna (Vuković) Vodnik
Milica Budimir FilimonovicMilica Budimir Filimonovic
Milica Budimir Filimonovic
Zoran M. MarkovicZoran M. Markovic
Zoran M. Markovic
SDSuzana Dimitrijević-Branković
Suzana Dimitrijević-Branković

15 January 2015 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
UBUna Bogdanović
Una Bogdanović
VVVesna (Vuković) Vodnik
Vesna (Vuković) Vodnik
MMMiodrag Mitrić
Miodrag Mitrić
SDSuzana Dimitrijević-Branković
Suzana Dimitrijević-Branković
SŠSrečo D. Škapin
Srečo D. Škapin
Milovan M. M. StoiljkovićMilovan M. M. Stoiljković
Milovan M. M. Stoiljković

16 November 2015 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
Svetlana JovanovićSvetlana Jovanović
Svetlana Jovanović
ZSZois Syrgiannis
Zois Syrgiannis
Zoran M. MarkovicZoran M. Markovic
Zoran M. Markovic
Aurelio BonaseraAurelio Bonasera
Aurelio Bonasera
Dejan KepićDejan Kepić
Dejan Kepić
BMBiljana M. Todorović Marković
Biljana M. Todorović Marković

1 June 2019 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
Zoran M. MarkovicZoran M. Markovic
Zoran M. Markovic
MKMaria Kovacova
Maria Kovacova
Petr HumpolíčekPetr Humpolíček
Petr Humpolíček
Milica Budimir FilimonovicMilica Budimir Filimonovic
Milica Budimir Filimonovic
JVJan Vajďák
Jan Vajďák
Zdenko SpitalskyZdenko Spitalsky
Zdenko Spitalsky

6 April 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Svetlana JovanovićSvetlana Jovanović
Svetlana Jovanović
ZMZoran Marković
Zoran Marković
Milica Budimir FilimonovicMilica Budimir Filimonovic
Milica Budimir Filimonovic
Jovana Prekodravac FilipovićJovana Prekodravac Filipović
Jovana Prekodravac Filipović
Danica ZmejkoskiDanica Zmejkoski
Danica Zmejkoski
BMBiljana M. Todorović Marković
Biljana M. Todorović Marković
The large number of deaths induced by carcinoma and infections indicates that the need for new, better, targeted therapy is higher than ever. Apart from classical treatments and medication, photodynamic therapy (PDT) is one of the possible approaches to cure these clinical conditions. This strategy offers several advantages, such as lower toxicity, selective treatment, faster recovery time, avoidance of systemic toxic effects, and others. Unfortunately, there is a small number of agents that are approved for usage in clinical PDT. Novel, efficient, biocompatible PDT agents are, thus, highly desired. One of the most promising candidates is represented by the broad family of carbon-based quantum dots, such as graphene quantum dots (GQDs), carbon quantum dots (CQDs), carbon nanodots (CNDs), and carbonized polymer dots (CPDs). In this review paper, these new smart nanomaterials are discussed as potential PDT agents, detailing their toxicity in the dark, and when they are exposed to light, as well as their effects on carcinoma and bacterial cells. The photoinduced effects of carbon-based quantum dots on bacteria and viruses are particularly interesting, since dots usually generate several highly toxic reactive oxygen species under blue light. These species are acting as bombs on pathogen cells, causing various devastating and toxic effects on those targets.